Recent events

Every US listed company has to file a Form 8-K within four business days of something significant happening, and tag it with the item number that says what kind of thing it was. This is that feed, over the last 180 days - the filings themselves, on EDGAR, one click away. Nothing here is a summary of what a filing said; it is what the company told SEC it was filing about.

Everything the market-wide feed shows by default: the rare events, plus management changes, restructurings, impairments, new debt and material agreements.

Date Company Event Filing
Synchrony Financial SYF Officer or director change Item 5.02 Form 8-K
Synergy CHC Corp. SNYR Officer or director change Item 5.02 Form 8-K
TENAX THERAPEUTICS, INC. TENX Officer or director change Item 5.02 Form 8-K
TOMI Environmental Solutions, Inc. TOMZ Material agreement signed Item 1.01 Form 8-K
TRANSACT TECHNOLOGIES INC TACT Officer or director change Item 5.02 Form 8-K
Tenaya Therapeutics, Inc. TNYA Officer or director change Item 5.02 Form 8-K
Theravance Biopharma, Inc. TBPH Material agreement signed Item 1.01 Form 8-K
U.S. GoldMining Inc. USGO Material agreement signed Item 1.01 Form 8-K
UNITED THERAPEUTICS Corp UTHR Officer or director change Item 5.02 Form 8-K
Volato Group, Inc. SOAR Material agreement signed Item 1.01 Form 8-K
Volato Group, Inc. SOAR Officer or director change Item 5.02 Form 8-K
ZIMMER BIOMET HOLDINGS, INC. ZBH Material agreement signed Item 1.01 Form 8-K
ZIMMER BIOMET HOLDINGS, INC. ZBH Material agreement terminated Item 1.02 Form 8-K
ZIMMER BIOMET HOLDINGS, INC. ZBH New debt or obligation Item 2.03 Form 8-K
Zymeworks Inc. ZYME Material agreement signed Item 1.01 Form 8-K
ADTRAN Holdings, Inc. ADTN Officer or director change Item 5.02 Form 8-K
ADVANCE AUTO PARTS INC AAP Officer or director change Item 5.02 Form 8-K
ALX ONCOLOGY HOLDINGS INC ALXO Material agreement signed Item 1.01 Form 8-K
ALX ONCOLOGY HOLDINGS INC ALXO Material agreement terminated Item 1.02 Form 8-K
ALX ONCOLOGY HOLDINGS INC ALXO New debt or obligation Item 2.03 Form 8-K
AUTOMATIC DATA PROCESSING INC ADP Material agreement signed Item 1.01 Form 8-K
AUTOMATIC DATA PROCESSING INC ADP New debt or obligation Item 2.03 Form 8-K
Akari Therapeutics Plc AKTX Material agreement signed Item 1.01 Form 8-K
Aligos Therapeutics, Inc. ALGS Officer or director change Item 5.02 Form 8-K
Applied Digital Corp. APLD Material agreement signed Item 1.01 Form 8-K
Applied Digital Corp. APLD New debt or obligation Item 2.03 Form 8-K
Atara Biotherapeutics, Inc. ATRA Officer or director change Item 5.02 Form 8-K
BERKLEY W R CORP WRB Officer or director change Item 5.02 Form 8-K
BIO-TECHNE Corp TECH Material agreement signed Item 1.01 Form 8-K
BIO-TECHNE Corp TECH Officer or director change Item 5.02 Form 8-K
Beyond Air, Inc. XAIR Annual report filed FY to 2026-03-31 Form 10-K
BridgeBio Pharma, Inc. BBIO Officer or director change Item 5.02 Form 8-K
Bristow Group Inc. VTOL Material agreement signed Item 1.01 Form 8-K
California Resources Corp CRC Material agreement signed Item 1.01 Form 8-K
California Resources Corp CRC New debt or obligation Item 2.03 Form 8-K
CareCloud, Inc. CCLD Material agreement signed Item 1.01 Form 8-K
Celldex Therapeutics, Inc. CLDX Officer or director change Item 5.02 Form 8-K
ChronoScale Holdings Corp CHRN Material agreement signed Item 1.01 Form 8-K
ChronoScale Holdings Corp CHRN New debt or obligation Item 2.03 Form 8-K
Cineverse Corp. CNVS Annual report filed FY to 2026-03-31 Form 10-K

Item numbers are Form 8-K's own. An 8-K says that a company filed about something, not what it decided - a management change under item 5.02 covers both a routine board retirement and a chief executive being removed, and only the filing tells you which. Dates are filing dates: an 8-K is due within four business days of the event, so the event itself is up to a week earlier. Events are collected from each company's SEC submissions index, which reaches back roughly a thousand filings - for a company that files often, that is less than three years.